US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class III · Low risk Terminated

Ondansetron Injection

Reason Failed Impurities/Degradation Specifications.

Fresenius Kabi USA, LLC NDC 63323-374-20 D-1386-2019
Class I · High risk Terminated

Amikacin Sulfate Injection

Reason Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .

Heritage Pharmaceuticals, Inc. NDC 23155-290-32 D-1398-2019
Class I · High risk Terminated

Prochlorperazine Edisylate Injection

Reason Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .

Heritage Pharmaceuticals, Inc. NDC 23155-294-31 D-1397-2019
Class II · Moderate risk Terminated

Bisacodyl Suppositories

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1385-2019
Class II · Moderate risk Terminated

RisperiDONE Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc NDC 23155-317-51 D-1382-2019
Class II · Moderate risk Terminated

Cetirizine Hydrochloride Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc NDC 13668-029-07 D-1381-2019
Class II · Moderate risk Terminated

Cetirizine Hydrochloride Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc NDC 23155-292-51 D-1380-2019
Class II · Moderate risk Terminated

Anu-Med brand of Hemorrhoidal Suppositories

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1379-2019
Class II · Moderate risk Terminated

Hemorrhoidal Suppositories

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1378-2019
Class II · Moderate risk Terminated

Laxative Suppositories

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1377-2019
Class II · Moderate risk Terminated

Hydrocortisone Acetate Suppositories

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1376-2019
Class II · Moderate risk Terminated

Memantine Hydrochloride Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1375-2019
Class II · Moderate risk Terminated

Memantine Hydrochloride Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1374-2019
Class II · Moderate risk Terminated

Lactulose Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1373-2019
Class II · Moderate risk Terminated

Lactulose Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1372-2019
Class II · Moderate risk Terminated

Nasal Decongestant Liquid

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1371-2019
Class II · Moderate risk Terminated

Diphenhist Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1370-2019
Class II · Moderate risk Terminated

Extra Action Cough Syrup

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1369-2019
Class II · Moderate risk Terminated

Cough Syrup

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1368-2019
Class II · Moderate risk Terminated

Kid Kare Childrens Cough/Cold Liquid

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1367-2019
Class II · Moderate risk Terminated

Pain & Fever Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1366-2019
Class II · Moderate risk Terminated

Phenobarbital Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1365-2019
Class II · Moderate risk Terminated

Guaifenesin DAC Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1364-2019